| Literature DB >> 32079440 |
Motoko Taguchi1,2,3, Kuniko Moto4,5, Sihyung Lee4, Suguru Torii1,3, Nobuko Hongu2,3.
Abstract
It has been reported that male athletes face increased risk for low energy availability and resulting health consequences similar to female athletes. The present study aimed to reveal the energy status of Japanese male runners and to examine the association between energy deficiency and physiological characteristics such as energy metabolism, bone health, and hormonal status. Six male collegiate long-distance runners during a training season participated in this study. Energy intake (EI) was assessed using 3-day dietary records with food pictures. Exercise energy expenditure (EEE) was determined by the HR-VO2 method. Body composition and bone status were measured by dual-energy X-ray absorptiometry. Energy availability (EA) was calculated by subtraction of EEE from EI and normalized by fat-free mass (FFM). Energy balance (EB) was calculated EI minus estimated total energy expenditure (TEE). Resting energy expenditure (REE) was measured by indirect calorimetry using the Douglas bag technique, and blood sampling was conducted to assess hormonal status. The mean EA of the subjects was 18.9 ± 6.8 kcal/kg FFM/day, and severe negative EB (range: -1444 ~ -722 kcal/d) was observed. REE of four runners was suppressed, and moreover, bone resorption was promoted in all subjects. The data in our study suggested that energy deficiency could promote bone resorption and energy metabolism suppression in Japanese male endurance runners. Additional short- and long-term studies are needed to clarify the health risks caused by energy deficiency in male athletes and explore strategies to prevent health problems related to energy deficiency in long-distance runners.Entities:
Keywords: bone resorption; energy availability; energy deficiency; male athletes; resting energy expenditure
Mesh:
Year: 2020 PMID: 32079440 PMCID: PMC7036509 DOI: 10.1177/1557988320905251
Source DB: PubMed Journal: Am J Mens Health ISSN: 1557-9883
Body Composition, Physical Characteristics, and Training Status of the Subjects.
| Sub 1 | Sub 2 | Sub 3 | Sub 4 | Sub 5 | Sub 6 | Mean | |
|---|---|---|---|---|---|---|---|
| Height (cm) | 175.0 | 172.0 | 168.0 | 169.5 | 171.0 | 174.5 | 171.7 ± 2.8 |
| Body weight (kg) | 58.3 | 54.0 | 59.6 | 56.5 | 55.0 | 55.4 | 56.4 ± 2.1 |
| BMI (kg/m2) | 19.0 | 18.3 | 21.1 | 19.7 | 18.8 | 18.2 | 19.2 ± 1.1 |
| Body fat (%) | 9.1 | 9.4 | 12.4 | 8.7 | 8.5 | 9.0 | 9.5 ± 1.4 |
| FFM (kg) | 53.0 | 48.9 | 52.2 | 51.6 | 50.3 | 50.4 | 51.0 ± 1.5 |
| VO2max (ml/kg/BW) | 61.1 | 59.2 | 58.2 | 56.6 | 59.8 | 57.0 | 58.6 ± 1.7 |
| Running distance (km/wk) | 121.0 | 108.8 | 142.8 | 115.5 | 122.5 | 182.8 | 132.2 ± 27.3 |
| Training start age (yrs) | 10 | 12 | 12 | 8 | 9 | 15 | 11 ± 3 |
| Athletic history (yrs) | 8.8 | 6.7 | 6.7 | 10.8 | 11.7 | 4.7 | 8.2 ± 2.7 |
Note. Mean data are presented as mean ± SD; BMI, body mass index; FFM, fat-free mass; BW, body weight; VO2max, maximal oxygen uptake.
Nutritional, Metabolic, and Bone Characteristics, and Reproductive Hormones of the Subjects.
| Sub 1 | Sub 2 | Sub 3 | Sub 4 | Sub 5 | Sub 6 | Mean | Clinical normal value | |
|---|---|---|---|---|---|---|---|---|
| Nutritional characteristics | ||||||||
| EI (kcal/d) | 2,586 | 2,382 | 2,380 | 2,488 | 2,385 | 2,673 | 2,482 ± 124 | |
| Protein (g/kg BW) | 1.9 | 1.9 | 1.9 | 1.6 | 1.5 | 2.5 | 1.9 ± 0.3 | |
| Fat (g/kg BW) | 1.5 | 1.5 | 1.1 | 1.5 | 1.3 | 1.4 | 1.4 ± 0.2 | |
| CHO (g/kg BW) | 5.7 | 5.8 | 5.6 | 5.9 | 6.2 | 6.3 | 5.9 ± 0.3 | |
| Ca (mg/d) | 858 | 844 | 1229 | 589 | 569 | 1033 | 855 ± 253 | |
| Fe (mg/d) | 9.5 | 7.9 | 9.7 | 10.5 | 9.9 | 9.6 | 9.5 ± 0.9 | |
| EAT 26 (point) | 2 | 1 | 7 | 14 | 11 | 5 | 7 ± 5 | <20 |
| Metabolic characteristics | ||||||||
| EEE (kcal/d) | 924 | 1,385 | 1,442 | 1,711 | 1,539 | 2,095 | 1,516 ± 386 | |
| TEE (kcal/day) | 3,308 | 3,679 | 3,927 | 4,139 | 3,989 | 4,518 | 3,927 ± 411 | |
| EB (kcal/d) | −722 | −1,297 | −1,547 | −1,650 | −1,604 | −1,845 | −1,444 ± 396 | |
| EA (kcal/kg FFM/d) | 31.4 | 20.4 | 18.0 | 15.1 | 16.8 | 11.5 | 18.9 ± 6.8 | >30 |
| REEm (kcal/d) | 1,350 | 1,351 | 1,337 | 1,340 | 1,387 | 1,296 | 1,344 ± 29 | |
| REEm (kcal/kg FFM/d) | 25.7 | 27.6 | 25.6 | 26 | 27.6 | 25.7 | 26.4 ± 1.0 | |
| REEp (kcal/d) | 1,591 | 1,404 | 1,498 | 1,536 | 1,438 | 1,467 | 1,489 ± 68 | |
| REE ratio | 0.85 | 0.96 | 0.89 | 0.87 | 0.96 | 0.88 | 0.90 ± 0.05 | |
| T3 (ng/dl) | 104 | 122 | 100 | 101 | 119 | 77 | 104 ± 16 | 58–159 |
| IGF-1 (ng/ml) | 162 | 246 | 145 | 204 | 271 | 179 | 201 ± 49 | 139–501 |
| Bone characteristics | ||||||||
| Total BMD (g/cm2) | 1.047 | 1.059 | 1.110 | 1.097 | 1.086 | 1.140 | 1.090 ± 0.034 | |
| Z-score | −1.7 | −1.5 | −1.4 | −0.9 | −0.9 | −0.1 | −1.1 ± 0.6 | > −1.0 |
| BAP (μg/L) | 17.5 | 24.5 | 13.7 | 11.3 | 25.4 | 14.9 | 17.9 ± 5.8 | 3.7–20.9 |
| NTX (nmol/L) | 19.8 | 25.1 | 38.4 | 28.8 | 23.6 | 35.1 | 28.5 ± 7.1 | 9.5–17.7 |
| 25(OH)D (ng/ml) | 23.1 | 17.3 | 21.6 | 23.2 | 22.8 | 19.6 | 21.3 ± 2.4 | 32–52a |
| Reproductive hormones | ||||||||
| LH (mIU/ml) | 5.19 | 2.64 | 2.98 | 2.01 | 2.72 | 2.27 | 3.00 ± 1.10 | 0.79–5.72 |
| E2 (pg/ml) | 17 | 16 | 18 | 18 | 28 | <10 | 18 ± 6 | 19–51 |
| TES (ng/ml) | 8.4 | 5.71 | 5.23 | 3.98 | 6.13 | 2.78 | 5.37 ± 1.93 | 1.92–8.84 |
Note. Mean data are presented as mean ± SD. EI, energy intake; CHO, carbohydrate; BW, body weight; EAT26, eating attitude test 26; EEE, exercise energy expenditure; TEE, total energy expenditure; EB, energy balance; EA, energy availability; REEm, measured resting energy expenditure; REEp, predicted resting energy expenditure; T3, triiodothyronine; IGF-1, insulin-like growth factor 1; FFM, fat-free mass; BMD, bone mineral density; BAP, bone-specific alkaline phosphatase; NTX, N-telopeptide of type I collagen; 25(OH)D, serum 25-hydroxyvitamin D; LH, luteinizing hormone; E2, estradiol; TES, testosterone. a, recommendation from RED-S (Mountjoy et al., 2014).